Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Kano, Osamu ^a   Iwamoto, Konosuke ^a   Ito, Hirono ^a   Kawase, Yuji ^a   Cridebring, Derek ^b   Ikeda, Ken ^a   Iwasaki, Yasuo ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Bulbar onset; Initial symptom; Limb onset; Neurologist; Orthopedist

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONSULTATION; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROLOGIST; NEUROSURGEON; ORTHOPEDIC SPECIALIST;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; EXTREMITIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PHYSICIANS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES;

EID: 84873461026     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-19     Document Type: Article

References (17)

1. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994, 124(Suppl):96-107.
2. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000, 1(5):293-299. 10.1080/146608200300079536, 11464847.
3. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996, 347(9013):1425-1431.
4. Chio A, Finocchiaro E, Meineri P, Bottacchi E, Schiffer D. Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group. Neurology 1999, 53(5):1123-1125. 10.1212/WNL.53.5.1123, 10496278.
5. Bourke SC, Bullock RE, Williams TL, Shaw PJ, Gibson GJ. Noninvasive ventilation in ALS: indications and effect on quality of life. Neurology 2003, 61(2):171-177. 10.1212/01.WNL.0000076182.13137.38, 12874394.
6. Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009, 73(15):1218-1226. 10.1212/WNL.0b013e3181bc0141, 2764727, 19822872.
7. Czaplinski A, Yen AA, Simpson EP, Appel SH. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Arch Neurol 2006, 63(8):1139-1143. 10.1001/archneur.63.8.1139, 16908741.
8. Testa D, Lovati R, Ferrarini M, Salmoiraghi F, Filippini G. Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period. Amyotroph Lateral Scler Other Motor Neuron Disord 2004, 5(4):208-212.
9. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 2002, 59(2):280-282. 10.1212/WNL.59.2.280, 12136072.
10. Iwasaki Y, Ikeda K, Kinoshita M. The diagnostic pathway in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2001, 2(3):123-126. 10.1080/146608201753275571, 11771767.
11. Turner MR, Scaber J, Goodfellow JA, Lord ME, Marsden R, Talbot K. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci 2010, 294(1-2):81-85.
12. Forbes RB, Colville S, Cran GW, Swingler RJ. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 2004, 75(12):1753-1755. 10.1136/jnnp.2003.024364, 1738850, 15548498.
13. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995, 118(Pt 3):707-719.
14. Iwasaki Y, Ikeda K, Ichikawa Y, Igarashi O, Kinoshita M. The diagnostic interval in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2002, 104(2):87-89. 10.1016/S0303-8467(01)00188-3, 11932036.
15. Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry 2003, 74(9):1258-1261. 10.1136/jnnp.74.9.1258, 1738639, 12933930.
16. Kihira T, Yoshida S, Okamoto K, Kazimoto Y, Ookawa M, Hama K, Miwa H, Kondo T. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci 2008, 268(1-2):95-101.
17. Yoshor D, Klugh A, Appel SH, Haverkamp LJ. Incidence and characteristics of spinal decompression surgery after the onset of symptoms of amyotrophic lateral sclerosis. Neurosurgery 2005, 57(5):984-989. discussion 984-989, 10.1227/01.NEU.0000180028.64385.d3, 16284567.